Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21461
Title: Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
Austin Authors: Wong, Eric ;Davis, Joanne;Koldej, Rachel;Szer, Jeff;Grigg, Andrew P ;Ritchie, David
Affiliation: Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
Medical Oncology
Department of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia
Australian Cancer Research Foundation Translation Research Laboratory, Sydney, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Jan-2020
metadata.dc.date: 2019-08-07
Publication information: Leukemia & lymphoma 2020; 61(1): 185-188
URI: http://ahro.austin.org.au/austinjspui/handle/1/21461
DOI: 10.1080/10428194.2019.1648803
PubMed URL: 31389281
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

10
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.